When integrating an IRT (IWR/IVR) system with an EDC platform, avoid collecting CRF data in the IRT. Optimal goals for deploying an IRT are to screen subjects (i.e., assign a Subject ID), to randomize subjects to a treatment group, and to assign drug to subjects during the trial. We recommend our clients follow a ‘must have’ approach for data collected in the IRT and subsequently pushed to the EDC – in most cases, limiting the data transferred to the Subject ID, Visit ID, and IP assigned.
New technological developments portend radical changes in the way the pharmaceutical industry will conduct clinical trials for new drug development in future – in fact, the rapid pace of techno-change predicts revolution in the wide arena of human health care.
But is it really a ‘revolution’ that looms on the horizon? Or is ‘evolution’ the better – and more welcome – description of the road that lies ahead?
In honor of the robust Pharma/Biotech industry here in our home state of North Carolina, Veracity Logic – a provider of IRT (IWR/IVR) services for clinical trials — has initiated its ‘Howdy Neighbor!’ program aimed at helping NC players get to know the companies and colleagues in their own backyard.
As part of that program, we’re now offering a 10% discount on startup costs for IRT services for members of the North Carolina Biosciences Organization (NCBIO). The discount is applicable to proposals initiated from May to the end of 2018.